Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Curry

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
The American Journal of Surgical Pathology|September 25, 2013
Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analysesMichael T Tetzlaff, Wei-Lien Wang, Tiffani L Milless, et al.
Acta Dermato-Venereologica|September 28, 2020
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic MelanomaHanna Eriksson, Johan Hansson, Britta Krynitz, et al.
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
Journal of Cutaneous Pathology|October 25, 2013
Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three casesPhyu Phyu Aung, Fina Climent, Tariq Muzzafar, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Journal of Cutaneous Pathology|June 22, 2020
Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transitionDongHyang Kwon, Shira Ronen, Alessio Giubellino, et al.
Melanoma Research|October 22, 2016
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patientsNitin Chakravarti, Doina Ivan, Van A Trinh, et al.
Cancer|August 8, 2013
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanomaAmanda D Bucheit, Erica Syklawer, John A Jakob, et al.
Human Pathology|June 12, 2025
INSM1: A highly sensitive marker for primary and metastatic Merkel cell carcinoma, superior to SOX11, pancytokeratin, and CK20Jeongeun Do, Yunyi Wang, Phyu P Aung, et al.
Journal of Cutaneous Pathology|November 11, 2018
Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spreadFaysal Fedda, Michael R Migden, Jonathan L Curry, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
The American Journal of Surgical Pathology|September 25, 2013
Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analysesMichael T Tetzlaff, Wei-Lien Wang, Tiffani L Milless, et al.
Acta Dermato-Venereologica|September 28, 2020
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic MelanomaHanna Eriksson, Johan Hansson, Britta Krynitz, et al.
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
Journal of Cutaneous Pathology|October 25, 2013
Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three casesPhyu Phyu Aung, Fina Climent, Tariq Muzzafar, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Journal of Cutaneous Pathology|June 22, 2020
Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transitionDongHyang Kwon, Shira Ronen, Alessio Giubellino, et al.
Melanoma Research|October 22, 2016
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patientsNitin Chakravarti, Doina Ivan, Van A Trinh, et al.
Cancer|August 8, 2013
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanomaAmanda D Bucheit, Erica Syklawer, John A Jakob, et al.
Human Pathology|June 12, 2025
INSM1: A highly sensitive marker for primary and metastatic Merkel cell carcinoma, superior to SOX11, pancytokeratin, and CK20Jeongeun Do, Yunyi Wang, Phyu P Aung, et al.
Journal of Cutaneous Pathology|November 11, 2018
Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spreadFaysal Fedda, Michael R Migden, Jonathan L Curry, et al.
Pageof 20